The new era of erectile dysfunction medicine ushered in by the availability of an effective and safe oral medication paves the evolution of the ®eld toward a multi-disciplinary and primary care setting. There exists a paucity of guidelines regarding the assessment and management of the patient with erectile dysfunction in the primary care arena. The`Process of Care' model for the evaluation and treatment of erectile dysfunction has been developed to advance new guidelines for the diagnosis and management of erectile dysfunction in the primary care and multi-disciplinary setting. This model was developed under the auspices of the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School (chairman: R Rosen) with input from a multi-disciplinary group of experts including representation from primary care, internal medicine, endocrinology, psychiatry, psychology and urology.{
Identi®cation of ED
The essential ®rst step in the management of ED is the taking of a thorough sexual, medical and psychosocial history. Clinicians should pay special attention to the sensitivity of the topic and to their patients' comfort level in discussing sexual problems. The history taking is also an opportunity for the physician to initiate patient and partner education and to facilitate communication. Outcomes related to this step in the process include: (1) characterization of the presenting problem, (2) assessment of the need for additional testing, and (3) decisions about referral or multi-disciplinary involvement.
A focused physical examination should be performed on every patient with erectile dysfunction. This examination does not differ substantially from routine primary care practice. However, greater emphasis is placed on the genito-urinary, vascular and neurologic systems. The physical examination may corroborate aspects of the medical history (eg poor peripheral circulation), and may occasionally reveal unsuspected physical ®ndings (eg penile plaques, small testes). The physical examination also provides an excellent opportunity for patient education and reassurance regarding normal genital anatomy. 1, 2 Select laboratory testing is recommended in all cases. Consensus exists regarding an investigation of the hypothalamic-pituitary-gonadal axis via assessment of serum testosterone and prolactin levels.
There is controversy about the relative value of the various testosterone assays, including total, free and bioavailable testosterone. 3 However, strong consensus exists that at least one of these assays should be performed. There is also agreement that routine serum prolactin determination should be performed. Although the test may be of low yield, elevated serum prolactin levels may be associated with potentially life-threatening diseases (eg pituitary adenoma), and are a readily reversible cause of erectile dysfunction. Standard serum chemistries, CBC and lipid pro®les may be of value and should be obtained, if not performed in the past year. Serum PSA determination should be conducted following the guidelines of the American Urological Association. Serum TSH determination may also be of value in select cases.
Upon completion of the ®rst stage in the process, the physician should be able to determine the medical status of the patient, to identify and characterize the erectile dysfunction, and to assess the need for additional testing and referral. Patient needs, expectations and priorities are an essential element in this assessment, as patients vary greatly in their acceptance of medical treatment for sexual disorders. Another important goal in this phase is for the physician to foster a therapeutic alliance with the patient and, if possible, with the patient's partner. Although not always possible on the ®rst visit, every effort should be made to involve the patient's partner early on in the process. 4 
Patient and partner assessment and education
The major topics and issues to be addressed in patient and partner education include: (1) basic review of the anatomy and physiology of the sexual response, (2) overview of relevant etiology and associated risk factors, particularly lifestyle factors (eg smoking, substance abuse) or prescription drug effects, (3) description of initial assessment and diagnostic testing results and (4) review of treatment options, including potential risks and bene®ts. The educational process also provides an opportunity for clari®cation of patient and partner's expectations and treatment needs. Finally, informed choice among the wide variety of treatment options and continued adherence to treatment are greatly enhanced by ongoing communication and education.
Situations often arise in which primary care physicians must ascertain the need for specialist consultation or referral for diagnostic testing for erectile dysfunction. 5 Indications for referral or consultation may arise at the time of the initial evaluation or during the course of treatment or follow-up. Common referral indications include: (1) younger patients with a history of pelvicaperineal trauma, who may bene®t from more specialized urologic studies to enable appropriate and potentially curative vascular surgery, (2) patients with signi®cant penile curvature (eg Peyronie's disease, congenital deformity) who may require surgical correction, (3) complicated endocrinopathies (eg secondary hypogonadism, pituitary adenoma), (4) complicated psychiatric or psychosexual disorders (eg refractory depression, hypoactive sexual desire) and (5) cases requiring vascular or neurosurgical intervention (eg aortic aneurysm, lumbosacral disc disease). Additionally, specialist referral may be indicated for further diagnostic testing at the request of the patient, his physician or for medico-legal reasons (eg worker's compensation claims).
Modi®cation of reversible causes
Erectile dysfunction is potentially reversible if speci®c etiological factors can be addressed. Among the potential reversible causes to be addressed are: (1) prescription or non-prescription drug use, (2) speci®c endocrinological conditions (eg hypogonadism, hyperprolactinemia), (3) pelvic or perineal trauma, (4) lifestyle and psychosocial factors (eg cigarette smoking, partner con¯ict). Some potentially modi®able factors or lifestyle issues, such as cigarette smoking or a poor partner relationship, are important to address, even though behavior change may be dif®cult to achieve in the short term. Although the quantitative bene®ts of risk factor modi®cation and lifestyle behavior changes are not documented, good clinical practice mandates attention to these issues either prior to or along with direct therapies for erectile dysfunction.
Step-wise therapy
The proposed treatment algorithm incorporates a step-wise progression of therapeutic interventions for erectile dysfunction. This step-wise model is based upon the four essential criteria of: (1) ease of administration, (2) reversibility, (3) invasiveness, and (4) cost. Patient and partner preferences should also be strongly considered in all cases. First line therapies may be used as single interventions or in combination (eg oral medication plus counseling). Second and third line therapies are generally reserved for those patients who show insuf®cient response to, or adverse effects from, one or more ®rst line therapies. 5, 6 First-line therapy oral erectogenic drugs vacuum constriction device therapy psychosexual therapy Second-line therapy intracavernosal injection therapy intraurethral therapy Third-line therapy penile prosthesis
In addition to the processes and actions shown, reassessment and follow-up should be conducted at regular intervals with every patient. 7 Important patient issues and concerns should be addressed as follows. First, patients may have concerns regarding treatment administration, presence of other sexual dysfunctions (eg premature ejaculation), partner issues (eg anorgasmia), or lifestyle factors. Patients may change medication regimens, either for ED or a concomitant medical disorder. The possibility of adverse drug reactions or interaction effects should be carefully monitored and the need for dosage titration or substitution of another intervention should be considered at each followup visit. Patients may change treatment preferences, seek new information, or wish to re-evaluate their current treatment choices. General medical and psychosocial reassessment should occur at regular intervals, depending upon the patient's health, physical needs and psychosocial needs. Regular patient follow-up visits are essential in evaluating the progress of therapy, as well as monitoring the sexual, general medical, and psychosocial status of the patient and partner.
